Content By Martin Dittmer and Brooke Cox

Martin Dittmer and Brooke Cox’s default image

By: Martin Dittmer and Brooke Cox

Despite the best efforts of pharmaceutical manufacturers, drug labeling is one of the greatest challenges in clinical trials, involving a complex, time-consuming process to meet strict regulatory requirements and obtain wide-ranging approvals from individual countries. That labels must contain a diverse range of information used by investigators, subjects and pharmaceutical companies alike compounds the problem.

Fortunately, a number of leading industrial automation companies are moving forward with new solutions and programs designed to ease the label-creation and -approval process for pharmaceutical manufacturers. Following is a closer look at the clinical-trials label processes, along with innovative technology tips like Web-based label approvals that hold promise for improving the current system.